Formic Acid

Formic Acid

SCHEMBL2879839

C[N+](C)(CCOc1ccccc1)Cc1cnc([C@](O)(c2ccccc2)C2CCCCC2)o1.O=C[O-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.37
CHRM2 P08172 7/20 0.37
CHRM1 P11229 7/20 0.37
KCNH2 Q12809 3/20 0.37
SLC6A3 Q01959 2/20 0.37
LMNA P02545 2/20 0.37
CHRM3 P20309 7/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 1/20 0.36
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA10 Q9GZZ6 1/20 0.35
CHRNA9 Q9UGM1 1/20 0.35
CYP19A1 P11511 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CHRM4 P08173 5/20 0.34
CHRM5 P08912 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL2879843 0.96 CHRNA7 (0.38) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL1109773 0.95 CHRNA7 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL1109774 0.95 CHRNA7 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL14101216 0.94 LMNA (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL4744134 0.92 CHRM3 (0.38) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL523702 0.90 KCNH2 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL4743353 0.90 KCNH2 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL4743389 0.90 KCNH2 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL524278 0.90 KCNH2 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3
SCHEMBL523703 0.90 KCNH2 (0.39) CHRNA7CHRM2CHRM1KCNH2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924570-B1 AZOLE AND THIAZOLE DERIVATIVES AND THEIR USE PULMAGEN THERAPEUTICS SYNERGY (GB) 2010-10-20 EP disclosed
US-20100113540-A1 Azole and Thiazole Derivatives and Their Use ARGENTA DISCOVERY LIMITED (GB) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113540-A1 Azole and Thiazole Derivatives and Their Use CHRM3, CHRM2, CHRM1 CHRNA7 42/4885CHRM2 2/4885CHRM1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.